Hexarelin: 2mg*10 vials
Hexarelin: 2mg*10 vials Original price was: $100.00.Current price is: $85.00.
Back to products
Gonadorelin: 2-5-10mg*10 vials
Gonadorelin: 2-5-10mg*10 vials Price range: $60.00 through $110.00

PT-141 (Bremelanotide): 10mg*10 vials

Original price was: $100.00.Current price is: $89.00.

Description

Buy PT-141 Peptide Kit (10 mg × 10 Vials)

What is PT-141?

PT-141 (Bremelanotide) is a synthetic peptide derived from α-MSH (alpha-melanocyte-stimulating hormone) and extensively investigated in melanocortin receptor signaling and neuroendocrine research. Its unique mechanism of action distinguishes it from many other peptides studied within the melanocortin family.

Key Facts

  • Also known as Bremelanotide
  • Synthetic melanocortin receptor agonist
  • Derived from α-MSH
  • Peptide length: 7 amino acids
  • Studied for more than two decades
  • Available as 10 mg × 10 vial kits
  • ≥99% HPLC purity verified
  • Certificate of Analysis (COA) available
  • Intended exclusively for laboratory research

Product Specifications

Specification Details
Compound PT-141
Alternative Name Bremelanotide
Peptide Type Melanocortin Receptor Agonist
Peptide Length 7 Amino Acids
Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Molecular Formula C50H68N14O10
Molecular Weight 1025.2 g/mol
Purity ≥99% HPLC Verified
Appearance White Lyophilized Powder
Strength 10 mg
Kit Size 10 Vials
Intended Use Laboratory Research Only

What Is PT-141?

PT-141, also known as Bremelanotide, is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH). It belongs to the melanocortin peptide family and has been extensively studied for its interaction with melanocortin receptors involved in neuroendocrine signaling.

Because of its distinct mechanism, PT-141 has become one of the most recognized melanocortin peptides in biomedical research.

Discovery and Development

PT-141 was developed from Melanotan II during investigations into melanocortin receptor biology. Research involving Bremelanotide contributed significantly to understanding melanocortin signaling and neuroendocrine pathways.

Mechanism of Action

Researchers investigate PT-141 for its interaction with:

  • Melanocortin receptors
  • α-MSH signaling pathways
  • Neuroendocrine physiology
  • Central nervous system signaling
  • Hormonal regulation mechanisms

PT-141 vs Melanotan II

Feature PT-141 Melanotan II
Origin α-MSH Analog α-MSH Analog
Family Melanocortin Peptide Melanocortin Peptide
Primary Research Area Neuroendocrine Signaling Melanocortin Biology
Structure Modified Cyclic Peptide Cyclic Peptide

Frequently Asked Questions

What is PT-141?

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist derived from alpha-melanocyte-stimulating hormone.

Is PT-141 the same as Bremelanotide?

Yes. PT-141 and Bremelanotide refer to the same compound.

What does PT-141 stand for?

PT-141 is the developmental code name assigned during the compound’s research and development.

What is PT-141 derived from?

PT-141 is derived from alpha-melanocyte-stimulating hormone (α-MSH) and was developed from Melanotan II.

Is PT-141 a peptide?

Yes. PT-141 is a synthetic peptide consisting of seven amino acids.

What receptor does PT-141 target?

Researchers investigate PT-141 for its activity at melanocortin receptors involved in neuroendocrine signaling.

What is the difference between PT-141 and Melanotan II?

Both compounds belong to the melanocortin family and are derived from α-MSH, but they differ structurally and exhibit distinct receptor-binding characteristics.

Where can I buy PT-141 online?

PT-141 research products are available from specialized peptide suppliers that provide HPLC purity testing, analytical verification, and Certificate of Analysis documentation.

Are there reliable suppliers of PT-141?

Researchers generally prioritize suppliers that maintain transparent quality standards, batch traceability, and analytical testing. Peptide Nexus Lab supplies research-grade PT-141 products supported by purity verification and COA documentation.

Is PT-141 approved by the FDA?

Bremelanotide has received FDA approval as a prescription medication under the brand name Vyleesi for a specific indication. However, bulk lyophilized PT-141 supplied in research formats is intended exclusively for laboratory research and is not approved for human or veterinary use.

Related Research Compounds

  • Melanotan II
  • Melanotan I
  • Kisspeptin-10
  • Oxytocin
  • CJC-1295 No DAC
  • Ipamorelin
  • MK-677

Expert Perspective

Research into melanocortin receptors has demonstrated their importance in neuroendocrine physiology and central nervous system signaling. PT-141 (Bremelanotide) remains one of the most extensively studied compounds within this peptide family.

Scientific References

  • Hadley ME et al. Studies involving melanocortin peptides.
  • Research concerning α-MSH analogs and melanocortin receptors.
  • Peer-reviewed literature on Bremelanotide and neuroendocrine signaling.

Research Use Only

PT-141 is intended strictly for laboratory research purposes. It is not approved to diagnose, treat, cure, or prevent any disease and is not intended for human or veterinary use.

Scientific Resources

For more detailed scientific information, you can visit the PubChem entry for PT-141.

Related Research Peptides

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “PT-141 (Bremelanotide): 10mg*10 vials”

Your email address will not be published. Required fields are marked *

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.